Robert Rafka - Discovery of a potent, selective, and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonylpyridine.

Document created by Robert Rafka on Aug 22, 2014
Version 1Show Document
  • View in full screen mode

  Publication Details (including relevant citation   information):

  J. Li, K. M. Lundy-DeMello, H. Cheng, S. M. Sakya, B. S. Bronk,   R. J. Rafka, B. H. Jaynes, C. B. Ziegler, C. Kilroy, D. W. Mann,   E. L. Nimz, M. P. Lynch, M. L. Haven, N. L. Kolosko, M. L.   Minich, C. Li, J. K. Dutra, B. Rast, R. Crossan, B. J. Morton, G.   W. Kirk, K. M. Callaghan, D. A. Koss, A. Shavnya, L. A. Lund, S.   B. Seibel, C. F. Petras, and A. Silvia (2004), Bioorg. Med. Chem.   Lett., 14, 95-98.


  Address (URL): http://